The government made this decision after the recommendation of the Health Products Regulatory Authority to resume immunization with the dose developed by the North American laboratory, after the authorities suspended vaccination due to cases of thrombosis that appeared in the United States.
South Africa announced on Thursday that it will resume vaccination against the coronavirus with the formula developed by the Johnson & Johnson laboratory, after authorities concluded that the health workers who had received the injection did not suffer blood clots.
The country had suspended immunization with this vaccine on April 13 as a precautionary measure after six North American women presented blood clots.
Khumbudzo Ntshavheni, Acting Minister of the Presidency, announced that following the recommendations presented to the Cabinet, the decision was made to lift the suspension: “The data reviewed had confirmed that South Africa had not experienced any rare blood clots with already vaccinated healthcare workers. The cabinet welcomes the recommendation of the South African Health Products Regulatory Authority to lift the suspension of the J&J vaccination program. Our scientists will continue to monitor all South Africans as they are vaccinated. “
The official indicated that the second phase of the immunization campaign would begin on May 17. The first phase of the program has not yet been completed. Of the more than 600,000 health workers who signed up to be vaccinated, some 290,000 have been immunized since the program began.
Ntshavheni also reported that South Africa has already purchased 30 million vaccines from Pfizer, in addition to the initial 10 million. The authorities, meanwhile, gave up using the vaccine developed by the AstraZeneca laboratory and the University of Oxford because it is less effective against the variant of the virus detected in that country.
For his part, he called on people over 60 years of age to register in the Electronic Vaccination Data System to access vaccination: “People without Internet access can register in person at more than 3,328 vaccination centers across the country. This represents an increase from the 2,088 initial vaccination points, and mobile phones will also be deployed to help the elderly, the homeless and those living in rural areas. “
The South African minister also acknowledged that the country registered a slight increase of 4.9% in coronavirus cases in the last two weeks. “The slight increase in cases is attributed to the reappearance of clusters in the Free State and the North Cape,” Ntshavheni said.
The cases went from 14,113 in the previous 14 days to 14,807 in the last 14 days.
In order to contain the spread of the virus, Ntshavheni maintained that the Government has already activated all the rapid response mechanisms to increase the traces of infected.
The Government of South Africa announced the suspension of vaccination against the coronavirus with the Johnson & Johnson drug following the decision of the United States for possible cases of thrombosis after the application of the vaccine.
The South African Minister of Health, Zweli Mkhize, indicated that the decision was adopted after the recommendation of the Centers for Disease Control and Prevention of the United States (CDC) and the Food and Drug Administration (FDA) of the North American country.
CDC and FDA made the recommendation as a “huge precaution” measure, after which the White House indicated in a statement that “said announcement will not have a significant impact on the vaccination plan” in the North American country.
The decision to temporarily suspend the use of the vaccines came after the newspaper ‘The New York Times’ reported that six people, who had been vaccinated with the J&J vaccine, suffered a series of thrombi in the two weeks after vaccination. , of which one of them died. These six cases, however, constitute a low percentage compared to the more than 6.8 million doses of the pharmaceutical company that were administered throughout the country.